Natalizumab Treatment Modulates Peroxisome Proliferator-Activated Receptors Expression in Women with Multiple Sclerosis

Peroxisome Proliferator-Activated Receptors (PPAR) are transcription factors suggested to be involved in inflammatory lesions of autoimmune encephalomyelitis and multiple sclerosis (MS). Our objective was to assess whether Natalizumab (NTZ) therapy is associated with alterations of PPAR expression i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PPAR Res
Main Authors: Ferret-Sena, Véronique, Maia e Silva, Alexandra, Sena, Armando, Cavaleiro, Inês, Vale, José, Derudas, Bruno, Chinetti-Gbaguidi, Giulia, Staels, Bart
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5203914/
https://ncbi.nlm.nih.gov/pubmed/28077943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/5716415
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados